Marchal, J. A., Prados, J., Melguizo, C., Gómez, J. A., Campos, J., Gallo, M. A., . . . Aránega, A. (1999). GR-891: A novel 5-fluorouracil acyclonucleoside prodrug for differentiation therapy in rhabdomyosarcoma cells. Nature Publishing Group.

Marchal, J A., J. Prados, C. Melguizo, J A. Gómez, J. Campos, M A. Gallo, A. Espinosa, N. Arena, und A. Aránega. GR-891: A Novel 5-fluorouracil Acyclonucleoside Prodrug for Differentiation Therapy in Rhabdomyosarcoma Cells. Nature Publishing Group, 1999.

Marchal, J A., et al. GR-891: A Novel 5-fluorouracil Acyclonucleoside Prodrug for Differentiation Therapy in Rhabdomyosarcoma Cells. Nature Publishing Group, 1999.